Type
1.
Grzybowski A, Sak J, Pawlikowski J, Iwanowicz-Palus G. Gerhard Henrik Armauer Hansen (1841-1912)--the 100th anniversary of the death of the discoverer of Mycobacterium leprae. Clinics in dermatology. 2013;31(5):653-55.
Type
1.
Strengholt. Sexual and reproductive health and rights services for people affected with leprosy or other disabilities. 2013. p. 28 p.
Type
1.
Veziris, Chauffour, Escolano, Henquet, Matsuoka. Resistance of M. leprae to Quinolones: A Question of Relativity? PLOS Neglected Tropical Diseases [Internet]. 2013; Available from: http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pntd.0002559&representation=PDF
Type
1.
Yang D, Chen J, Shi C, Jing Z, Song N. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines. Inflammation. 2013;
Type
1.
Rojas-Espinosa O, Arce-Paredes P, Juarez-Ortega M, Hernandez V, Villanueva E, Aguilar-Santelises M. Induction and treatment of anergy in murine leprosy. International journal of experimental pathology [Internet]. 2014; Available from: http://onlinelibrary.wiley.com/doi/10.1111/iep.12108/epdf
Type
1.
Zziwa, Walker. Newly diagnosed leprosy patients at a rural treatment centre in Uganda have high rates of grade 2 disability. International Research on Medical Sciences [Internet]. 2013;1(4):035-39. Available from: http://apexjournal.org/pdf/Zziwa%20and%20Walker.pdf
Type
1.
Paschoal JAA, Paschoal VD, Nardi SMT, Rosa PS, Ismael MGS, Sichieri EP. Identification of urban leprosy clusters. TheScientificWorldJournal. 2013;2013:219143.
Type
1.
Masaki T, McGlinchey A, Cholewa-Waclaw J, Qu J, Tomlinson S, Rambukkana A. Innate immune response precedes mycobacterium leprae-induced reprogramming of adult Schwann cells. Cellular reprogramming. 2013;
Type
1.
Antunes DE, Araujo S, Ferreira GP, Cunha ACSR, Costa AV, Gonçalves MA, et al. Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy. Memórias do Instituto Oswaldo Cruz [Internet]. 2013;108(7):901-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970646/pdf/0074-0276-mioc-108-07-00901.pdf
Type
1.
Schalcher TR, Vieira JLF, Salgado CG, Borges RDS, Monteiro MC. Antioxidant factors, nitric oxide levels, and cellular damage in leprosy patients. Revista da Sociedade Brasileira de Medicina Tropical. 2013;46(5):645-9.
Pagination
- Previous page
- Page 482
- Next page